Navigation Links
Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
Date:11/8/2007

SEATTLE, Nov. 8 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced presentation of positive data from a Phase IIb study that showed that Trubion's TRU-015 for rheumatoid arthritis (RA) provided statistically significant efficacy after a single infusion of 800 mg or 1,600 mg. In addition, Trubion also announced presentation of data showing that repeat administration with TRU-015 was well tolerated and resulted in a consistent pharmacokinetic (PK) and pharmacodynamic (PD) profile. Trubion is co-developing TRU-015 with Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), for the treatment of rheumatoid arthritis.

These data will be presented during two poster sessions at the annual meeting of the American College of Rheumatology (ACR) on Nov. 8 and 9, 2007. The posters are available in the Events section of Trubion's Web site at http://investors.trubion.com/events.cfm.

"TRU-015's ability to significantly improve RA signs and symptoms following a single infusion could represent a new level of convenience for patients and physicians. These results also suggest that clinical responses may be maintained during B-cell recovery," said Peter Thompson, M.D., FACP, president, chief executive officer and chairman of Trubion. "We and our partner have agreed on a design for our next study that we believe could be supportive of a registration package, and we look forward to TRU
'/>"/>

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...EW YORK, July 24 /- MacroCh...nounced results of a Phase 2 clinical trial,involv...i-center,open-label efficacy and safety study of ...tment of onychomycosis (nail fungus). The composit...lete cure" defined as,negative mycology (negative ...
(Date:7/23/2008)...tudy results pending publication in July print edi...vailable on Web, INDIANAPOLIS, July 23 /PRNewswir...aluating the use of N-terminal pro-B-type natriure...ue of NT-proBNP for risk,stratification in predict...AE) in patients treated with non-steroidal anti-in...
(Date:7/23/2008)...OSTON, July 23 /- FluoroPharma Inc., ...g agents for the Positron Emission Tomography,(PET...FPET, its novel,Fluorine-18 labeled tracer for myo... second cardiovascular product to complete Phase I...ent, designed to assess the blood flow in the,hear...
(Date:7/23/2008)...EATTLE, July 23 /- Dendreon... it expects the Independent Data,Monitoring Commit...nalysis,of overall survival relating to the Compan...noCarcinoma Treatment, also known as D9902B) clini...is the Company,s investigational,active cellular i...
Breaking Medicine Technology:MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Largest Ever Regional AIDS Conference to Review Epidemic Status and Changing Challenges in the Response 18253 1Largest Ever Regional AIDS Conference to Review Epidemic Status and Changing Challenges in the Response 18253 2Largest Ever Regional AIDS Conference to Review Epidemic Status and Changing Challenges in the Response 18253 3Largest Ever Regional AIDS Conference to Review Epidemic Status and Changing Challenges in the Response 18253 4Stinger Systems Inc Settles With the SEC 3158 1Male seahorses are natures Mr Mom Texas A 26M researchers say 3155 1Male seahorses are natures Mr Mom Texas A 26M researchers say 3155 2Male seahorses are natures Mr Mom Texas A 26M researchers say 3155 3Male seahorses are natures Mr Mom Texas A 26M researchers say 3155 4Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference 5057 1Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference 5057 2
...ented at 2007 APA Meeting Also Showed No,Significa...COLLEGEVILLE, Pa., May 21, 2007 /PRNewswire-FirstC... - one examining the,effect of desvenlafaxine succ... symptoms associated with major depressive disorde...hat examined the,effect of desvenlafaxine succinat...
...7 Percent Reduction in Risk of Hospitalization,fro...PARK, Ill., May 22, 2007 /PRNewswire-FirstCall/ --...alysis of a pivotal study,presented at the Digesti... showing patients with moderate to severely active...b) maintenance,therapy were almost 60 percent less...
Other Medicine Technology:Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 2Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 4Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 5Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 6New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 2New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 3New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 4New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 5New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 6New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 7
(Date:7/25/2008)... Whether you are an Olympian, Professional ...re Five Things You Need to Know about Hydration to... and Sports Center , Mari...a,s premier athletes are heading to Beijing follow...crifice in the hopes of capturing an Olympic medal...
(Date:7/25/2008)... This donation will be used to facilitate t...es for children , Hauppau...ci.com ), a leading integrator of enterprise coll...o conferencing, telepresence, audio visual integra... today that it has donated video conferencing equi...
(Date:7/24/2008)..., N.C. Researchers at Wake Forest University Bap... clinical belief that the hepatitis C virus slows ...tself after HIV patients are treated with a combin...itis C (HCV) infection is more serious in HIV-infe...ing to the Centers for Disease Control. Intravenou...
(Date:7/24/2008)...ly 24 /PRNewswire-USNewswire/ -- Speaker Nancy Pel...in support of the Tom Lantos,and Henry J. Hyde Glo...,Malaria Reauthorization Act of 2008. The bill, wh...this evening by a vote of 303 to 115 and will now ...day the House took an historic vote to pass landma...
Breaking Medicine News(10 mins):Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3Health News:Pelosi Statement on House Passage of Global AIDS Legislation 2
... have come out with study results that encourage h...er of lymph nodes// marked by the presence of tu...ollow up. This, researchers opine, may be a defini... was shown to be positively associated with risks ...
...to experts, the Victorian disease tuberculosis is ...ction Agency of UK show// an increase by 2 percent...gures, released ahead of World TB Day, which falls...rovisional and relate to England, Wales and Northe...
...tudy finds that traditional Chinese medical belief...jing, China.// Jacqueline Hom, a dental student a...A, USA), reports her findings today during the 85t...ternational Association for Dental Research. Over...
...Health Organisation (WHO) has claimed that the glo...r the first time since it declared TB a public hea...Control Report released today, two days before the...of the world's population struck by TB peaked in 2...
Other Medicine News:Health News:Doctors Warned to Keep Track of Tumorous Lymph Nodes 2Health News:TB Cases on the Rise 2Health News:Global Tuberculosis Epidemic Levelling Off - WHO 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: